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Asymptomatic patient with “lumpy and bumpy” airways. 
A case of pulmonary MALToma
Abstract
Primary pulmonary lymphoma is a rare disease. The most frequent primary pulmonary lymphoma (PPL) is an extranodal marginal 
zone B-cell lymphoma of MALT. Approximately half of the patients are asymptomatic at diagnosis. In this article, we report 
a case of a 62-year-old male with benign prostatic hyperplasia (BPH) that was referred to us for a preoperative assessment. He 
had no respiratory complaints but, on evaluation, was detected to have a pulmonary MALToma. Our case highlights the fact that 
pulmonary MALTomas can present as lumpy and bumpy airways and also aims to showcase the importance of tissue diagnosis.
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Introduction 
While gastric maltoma is a relatively well 
known entity, pulmonary MALToma is rare. It 
may not cause any symptoms and may be de-
tected inadvertently when the patient is being 
evaluated for some other disease. Radiological 
findings are also non-specific [1]. We report a case 
of a 62-year-old male referred to us for preopera-
tive assessment for benign prostatic hyperplasia 
(BPH), who, upon evaluation, was detected to 
have pulmonary MALToma. Radiologically, he 
had nodular lesions with peribronchovascular 
predominance. Fiberoptic bronchoscopy revealed 
multiple diffuse nodules along the wall of tra-
chea, the right and left main bronchus, and in the 
deeper airways. Endobronchial and transbron-
chial biopsy confirmed the diagnosis. Our case is 
interesting because pulmonary MALTomas very 
rarely manifest as lumpy and bumpy airways or 
contain multiple, tiny nodules seen on fiberoptic 
bronchoscopy.
Case report
A 62-year-old male was referred to a chest 
clinic for preoperative assessment in preparation 
for surgery for BPH. He denied any history of fe-
ver, cough, shortness of breath, haemoptysis, or 
chest pain. The patient had been diagnosed with 
diabetes mellitus for 10 years which was well 
controlled on oral hypoglycemic drugs. He never 
smoked or consumed alcohol. On examination, 
digital clubbing was present. There was no pallor, 
icterus, cyanosis, edema, or lymphadenopathy. 
His vitals were as follows: BP was 120/70 mm Hg; 
pulse rate — 86/min; respiratory rate — 18/min; 
temp. — 98.6°F; and SpO2 on room air — 95%. 
On auscultation of the chest, end inspiratory 
crepitations were present in bilateral infra-scap-
ular areas. His hemoglobin was 15 gm/dL, total 
leucocyte count was 7800/cmm, and his liver 
and renal function tests were within normal 
limits. A chest radiograph revealed bilateral 
multiple small nodular opacities in the mid and 
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lower lung zones. High resolution computed to-
mography (HRCT) of the thorax showed multiple 
nodular lesions of varying size predominantly in 
the bilateral lower lobes with peribronchovascu-
lar predominance. Narrowing of the right main 
bronchus with nodular bronchial wall thickening 
was also seen (Figure 1, 2).
Flexible fiberoptic bronchoscopy showed 
multiple diffuse nodules along the wall of the 
trachea, right and left main bronchus, and in 
the deeper airways (Figure 3). Bronchial and 
trans-bronchial lung biopsies were taken and 
sent for histopathological examination. As sar-
coidosis was in the differential diagnosis, se-
rum calcium, 24-hour urinary calcium, and 
angiotensin converting enzyme levels were sent 
for evaluation. Serum calcium was 9.5 mg/dL, 
24-hour urinary calcium was 150 mg, and the 
ACE level was 50 U/L. An endobronchial biopsy 
revealed tissue lined by bronchial mucosa (pseu-
dostratified columnar epithelium). Submucosal 
tissue showed infiltration with small to medium 
sized atypical lymphoid cells, centrocyte-like 
cells, lymphoepithelial lesions and Dutcher bod-
ies. Transbronchial lung biopsy showed similar 
atypical lymphoid cells infiltrating into the lung 
parenchyma. IHC was positive for CD20, CD3, 
CD43, CD138, and Bcl2. Lymphoepithelial lesions 
were CK-positive. CD5 and CD10 were negative. 
No light chain restriction was present (Figures 
4–6). Based on histopathological examination 
and immunophenotypical features, a diagnosis 
of extra nodal marginal zone B cell lymphoma of 
mucosa associated lymphoid tissue (Pulmonary 
MALToma) was made and the patient was started 
on the R-CHOP regimen. He had received 3 cycles 
of chemotherapy up until the time of the writing 
of this article. After 3 cycles of R-CHOP, chest 
x-ray and HRCT of the chest showed a significant 
resolution of nodular lesions.
Discussion
Primary pulmonary lymphoma is a rare enti-
ty. It is defined as a lymphoma involving one or 
both lungs without any extrapulmonary or bone 
marrow involvement at the time of diagnosis or 
in the subsequent 3 months after diagnosis [2]. 
The most frequent primary pulmonary lymphoma 
(PPL) is extranodal marginal zone B-cell lympho-
ma of MALT [3]. MALT lymphomas account for 
less than 0.5% of all primary lung cancers. MALT 
lymphomas are low grade B-cell neoplasms [4]. 
They most commonly involve the gastric mucosa. Figure 1. Radiograph of chest posteroanterior view
Figure 2. High resolution computed tomography of chest
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Figure 3. Bronchoscopy image of the trachea, carina, and right intermediate bronchus
However, non-gastric site involvement may be 
seen in the large and small bowels, breasts, head 
and neck, lungs, dura matter, ocular adnexa, 
skin, parotid glands, prostate, and ovaries. They 
are believed to arise because of chronic antigen-
ic stimulation associated with smoking, local 
chronic inflammatory disease, or autoimmune 
diseases. An association of gastric MALToma with 
Helicobacter pylori, ocular adnexal MALToma 
with Chlamydia psittaci, cutaneous MALToma 
with Borrelia burgdorferi, and hepatic MALToma 
with Hepatitis C virus has been proven. However, 
no such association of any infective agent with 
pulmonary MALToma is known [5]. 
It is most commonly seen in elderly patients 
with a slight male preponderance. It tends to 
remain localized to the lungs for long periods of 
time, follows an indolent course, and is associ-
ated with a good prognosis. Most of the patients 
are asymptomatic at diagnosis. Symptoms, when 
present, can be non-specific [1]. Radiological 
findings are also non-specific. The most common 
radiologic manifestation consists of a solitary 
nodule or a focal area of consolidation [6]. In our 
case, flexible fiberoptic bronchoscopy showed 
multiple diffuse nodules along the wall of the 
trachea, right and left main bronchus, and in the 
deeper airways. A nodular or lumpy appearance 
of the trachea and bronchi give the appearance 
of cobblestones. A cobblestone appearance of the 
trachea has been classically described in tracheo-
bronchopathia osteoplastica (TPO) [7]. However, 
it can also be seen in sarcoidosis [8], relapsing 
polychondritis (RP) [9], amyloidosis [10], granu-
lomatosis with polyangitis [11], and lymphoma 
[12]. In TPO and RP, nodules do not involve the 
posterior wall of the trachea [13]. Nodular lesions 
involving the trachea and bronchi are exceedingly 
rare in pulmonary MALToma [14–17]. 
Diagnostic yield of bronchial & transbronchi-
al biopsy is higher when visible endobronchial 
lesions are targeted. A diagnosis of MALT type 
NHL is based on histological examination of sur-
gical samples or bronchial/transbronchial biopsy 
material. Immunohistochemical analysis shows 
a B-cell phenotype (CD19, CD20), persistence of 
dendritic cells (CD21, CD35), and the presence 
of small reactive T lymphocytes (CD3) in alveolar 
wall infiltrate and around peribronchial nodules 
[18, 19].
Treatment depends upon the extent of the 
disease. Optimal management remains unclear. It 
has been suggested that since it has an indolent 
course, observation is preferable. However, this 
approach should be used with caution and only 
in highly selective patients, especially those in 
whom diagnostic biopsy was excisional. Surgical 
Figure 4. Endobronchial biopsy showing submucosal bronchial tissue 
with small to medium sized lymphoid cells, centrocyte-like cells (black 
arrow), lymphoepithelial lesions, and Dutcher bodies (arrowhead)
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Figure 5. Transbronchial lung biopsy showing similar atypical lymphoid cells infiltrating into the lung parenchyma
Figure 6.  A. CD20 positive B cells; B. CD3 reactive T cells; C. CD43 positive B cells; D. Bcl2 positive B cells
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resection is the treatment of choice for localized 
resectable pulmonary MALTomas. For unresect-
able disease, involved site radiation therapy 
(ISRT) or chemo-immunotherapy can be used [20].
Conclusion
The clinical and radiological presentation of 
our case closely mimicked sarcoidosis. However, 
biopsy confirmed the diagnosis of pulmonary 
MALToma. It is a rare disease. Non-specific 
symptoms and non-specific radiological findings 
make it difficult to diagnose. It can present with 
multiple nodular protrusions involving the tra-
chea and bronchi. Histopathology confirms the 
diagnosis. This case highlights the importance of 
tissue diagnosis, especially when the radiology is 
suggestive of some other diseases.
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